Linzagolix choline

CAS No. 1321816-57-2

Linzagolix choline( —— )

Catalog No. M34100 CAS No. 1321816-57-2

Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Linzagolix choline
  • Note
    Research use only, not for human use.
  • Brief Description
    Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
  • Description
    Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GNRH Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1321816-57-2
  • Formula Weight
    611.59
  • Molecular Formula
    C27H28F3N3O8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C([O-])C=1SC=C2NC(=O)N(C(=O)C21)C=3C=C(OCC4=C(F)C(F)=CC=C4OC)C(OC)=CC3F.OCC[N+](C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Panadiplon

    Panadiplon (FG 10571) is a selective gamma-aminobutyric acid receptor agonist and partial agonist of 5GABAA, a benzodiazepine receptor, used in the treatment of anxiety disorders.

  • Pomalidomide-C6-COOH

    Pomalidomide-C6-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.

  • Tinurilimab

    Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.